ProUroCare Medical (PUMD) Stock Analysis & Winston Score

ProUroCare Medical Inc. is a small medical device company focused on tools that help doctors monitor and treat prostate conditions in men. Its core product is the ProUroScan system, a device that uses ultrasound technology to create detailed images of the prostate gland, helping urologists detect abnormalities. The company sells primarily to urology clinics and healthcare providers in the United States.

The company generates revenue by selling or licensing its imaging hardware and related technology to medical practices. ProUroCare is very small, with essentially no meaningful revenue at this stage, which explains the near-zero gross and operating margins despite an unusual ROIC figure. The biggest risk the company faces is achieving regulatory clearance, building a sales network, and securing enough funding to grow before its cash runs out — challenges that are common for early-stage medical device companies trying to gain traction in a competitive healthcare market.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

+33.3% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

22.7%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~0 months

$970 cash & investments

Short runway — potential dilution ahead through share issuance

Cash watch

ProUroCare Medical has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

N/A

—

Data not available

Operating Margin

N/A

—

Data not available

ROCE

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

N/A

—

Data not available

EPS YoY

N/A

—

Data not available

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

—

Data not available

FCF Margin

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

—

Data not available

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial